GSA Capital Partners’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Buy
73,975
+39,423
+114% +$849K 0.13% 143
2026
Q1
$396K Sell
34,552
-1,337
-4% -$18.8K 0.02% 1070
2025
Q4
$516K Buy
35,889
+136
+0.4% +$2.35K 0.04% 785
2025
Q3
$677K Buy
35,753
+25,199
+239% +$415K 0.06% 648
2025
Q2
$226K Sell
10,554
-4,988
-32% -$74.2K 0.02% 1437
2025
Q1
$204K Buy
+15,542
New +$231K 0.02% 1388
2024
Q4
Sell
-37,508
Closed -$796K 1915
2024
Q3
$796K Sell
37,508
-78,923
-68% -$1.42M 0.06% 609
2024
Q2
$1.84M Buy
116,431
+77,283
+197% +$1.42M 0.13% 176
2024
Q1
$582K Sell
39,148
-40,873
-51% -$560K 0.05% 793
2023
Q4
$732K Sell
80,021
-23,763
-23% -$164K 0.06% 564
2023
Q3
$578K Buy
103,784
+81,460
+365% +$570K 0.05% 702
2023
Q2
$180K Buy
+22,324
New +$165K 0.02% 1298
2022
Q2
Sell
-220,920
Closed -$2.2M 1695
2022
Q1
$2.2M Buy
+220,920
New +$1.64M 0.3% 15

Other funds holding OSCR

GSA Capital Partners's OSCR Position: Q2 2026 in Review

GSA Capital Partners increased its Oscar Health (OSCR) stake by 114% in Q2 2026, buying an estimated $849K and bringing the position to 73,975 shares worth $2.11M. The position accounts for 0.13% of the portfolio, ranked #143.

GSA Capital Partners first reported a position in OSCR in Q1 2022 and has held it in 13 quarters since. The position peaked at $2.2M in Q1 2022. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • GSA Capital Partners held 73,975 shares of Oscar Health worth $2.11M as of Q2 2026.
  • GSA Capital Partners bought 39,423 Oscar Health shares in Q2 2026, an estimated $849K.
  • Oscar Health made up 0.13% of GSA Capital Partners's portfolio in Q2 2026, its #143 holding.
  • GSA Capital Partners first reported a position in Oscar Health in Q1 2022 and has held it in 13 quarters since.
  • GSA Capital Partners's Oscar Health position peaked at $2.2M in Q1 2022.
  • 402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.